Risk of Guillain-Barré syndrome decreases after COVID-19 vaccination

By | December 15, 2021
A new study suggests that low GBS incidence in vaccinated patients compared to non-vaccinated people should encourage the active propagation of vaccination against SARS-CoV-2.